A&P LIFESCIENCE FUND, FI
•CLASE B
Cartera Renta Variable
2024-Q2 | ||||
---|---|---|---|---|
1 | ELI LILLY AND CO | 190.153 € | 5.75% | 60.05% |
2 | ALNYLAM PHARMACEUTICALS INC | 149.933 € | 4.53% | 75.4% |
3 | AGIOS PHARMACEUTICALS INC | 129.726 € | 3.92% | 99.51% |
4 | IONIS PHARMACEUTICALS INC | 111.265 € | 3.37% | 2.92% |
5 | AXSOME THERAPEUTICS INC | 104.147 € | 3.15% | 4.22% |
6 | CRISPR THERAPEUTICS AG | 97.453 € | 2.95% | 11.1% |
7 | VIKING THERAPEUTICS INC | 97.034 € | 2.93% | 124.31% |
8 | SYNDAX PHARMACEUTICALS INC | 96.010 € | 2.9% | 24.42% |
9 | AMGEN INC | 89.830 € | 2.72% | 27.05% |
10 | KURA ONCOLOGY INC | 87.776 € | 2.65% | 47.54% |
11 | ARROWHEAD PHARMACEUTICALS INC | 79.258 € | 2.4% | 1.27% |
12 | VIRIDIAN THERAPEUTICS INC | 74.601 € | 2.26% | 6.2% |
13 | GENMAB A/S | 71.944 € | 2.18% | 3.89% |
14 | BOSTON SCIENTIFIC CORP | 67.140 € | 2.03% | 62.49% |
15 | SPRINGWORKS THERAPEUTICS INC ORDINARY SHARES | 64.876 € | 1.96% | 6.35% |
16 | ABBOTT LABORATORIES | 62.367 € | 1.89% | 2.72% |
17 | KEROS THERAPEUTICS INC | 61.044 € | 1.85% | 34.73% |
18 | EDWARDS LIFESCIENCES CORP | 60.873 € | 1.84% | 48.36% |
19 | NEUROCRINE BIOSCIENCES INC | 57.186 € | 1.73% | Nueva |
20 | SAREPTA THERAPEUTICS INC | 55.602 € | 1.68% | 68.84% |
21 | IDEAYA BIOSCIENCES INC | 55.452 € | 1.68% | 1.68% |
22 | MEDTRONIC PLC | 52.899 € | 1.6% | 1.55% |
23 | BRIDGEBIO PHARMA INC | 51.686 € | 1.56% | Nueva |
24 | CULLINAN THERAPEUTICS INC | 51.280 € | 1.55% | 76.36% |
25 | PROTAGONIST THERAPEUTICS INC | 50.909 € | 1.54% | Nueva |
26 | ABBVIE INC | 50.273 € | 1.52% | 42.11% |
27 | CYTOKINETICS INC | 49.866 € | 1.51% | Nueva |
28 | MADRIGAL PHARMACEUTICALS INC | 47.334 € | 1.43% | Nueva |
29 | ZIMMER BIOMET HOLDINGS INC | 46.905 € | 1.42% | 39.04% |
30 | 4D MOLECULAR THERAPEUTICS INC ORDINARY SHARES | 44.574 € | 1.35% | Nueva |
31 | REGENERON PHARMACEUTICALS INC | 44.149 € | 1.34% | 23.31% |
32 | VERONA PHARMA PLC ADR | 39.494 € | 1.19% | 16.71% |
33 | MIRUM PHARMACEUTICALS INC | 38.297 € | 1.16% | Nueva |
34 | GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 38.258 € | 1.16% | 82.68% |
35 | THERMO FISHER SCIENTIFIC INC | 35.617 € | 1.08% | 7.35% |
36 | MINERALYS THERAPEUTICS INC | 35.298 € | 1.07% | 40.19% |
37 | DANAHER CORP | 34.284 € | 1.04% | 11.29% |
38 | 百济神州有限公司 ADR | 34.226 € | 1.04% | 18.49% |
39 | CELLDEX THERAPEUTICS INC | 32.716 € | 0.99% | 31.59% |
40 | PLIANT THERAPEUTICS INC ORDINARY SHARES | 31.930 € | 0.97% | 20.5% |
41 | RESMED INC | 31.626 € | 0.96% | 14.66% |
42 | ARVINAS INC | 31.359 € | 0.95% | 33.36% |
43 | CRINETICS PHARMACEUTICALS INC | 30.437 € | 0.92% | Nueva |
44 | SANOFI SA ADR | 29.167 € | 0.88% | 50.92% |
45 | AMICUS THERAPEUTICS INC | 28.640 € | 0.87% | 27.97% |
46 | ROCHE HOLDING AG ADR | 27.411 € | 0.83% | 1.4% |
47 | ROCKET PHARMACEUTICALS INC | 26.408 € | 0.8% | Nueva |
48 | KYMERA THERAPEUTICS INC ORDINARY SHARES | 26.136 € | 0.79% | 110.25% |
49 | BECTON DICKINSON & CO | 25.961 € | 0.79% | 52.64% |
50 | TANGO THERAPEUTICS INC | 24.027 € | 0.73% | Nueva |
51 | BLUEPRINT MEDICINES CORP | 23.844 € | 0.72% | 20.41% |
52 | AKERO THERAPEUTICS INC | 23.432 € | 0.71% | 3.53% |
53 | 89BIO INC ORDINARY SHARES | 23.328 € | 0.71% | 26.11% |
54 | PENUMBRA INC | 22.847 € | 0.69% | 26.28% |
55 | NOVARTIS AG ADR | 18.981 € | 0.57% | 45.82% |
56 | MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 18.716 € | 0.57% | Nueva |
57 | ARCUTIS BIOTHERAPEUTICS INC ORDINARY SHARES | 10.574 € | 0.32% | Nueva |
58 | NEUMORA THERAPEUTICS INC | 4377 € | 0.13% | Nueva |
59 | VERALTO CORP | 4367 € | 0.13% | 19.61% |
60 | SANDOZ GROUP AG ADR | 2568 € | 0.08% | 16.52% |
2024-Q4 | ||||
---|---|---|---|---|
1 | ELI LILLY AND CO | 167.777 € | 5.76% | 11.77% |
2 | ALNYLAM PHARMACEUTICALS INC | 150.237 € | 5.16% | 0.2% |
3 | VERONA PHARMA PLC ADR | 131.250 € | 4.51% | 232.33% |
4 | AXSOME THERAPEUTICS INC | 113.271 € | 3.89% | 8.76% |
5 | IONIS PHARMACEUTICALS INC | 84.454 € | 2.9% | 24.1% |
6 | BOSTON SCIENTIFIC CORP | 80.580 € | 2.77% | 20.02% |
7 | AMGEN INC | 77.540 € | 2.66% | 13.68% |
8 | VIKING THERAPEUTICS INC | 76.220 € | 2.62% | 21.45% |
9 | CRISPR THERAPEUTICS AG | 73.489 € | 2.52% | 24.59% |
10 | ABBOTT LABORATORIES | 70.250 € | 2.41% | 12.64% |
11 | AGIOS PHARMACEUTICALS INC | 67.574 € | 2.32% | 47.91% |
12 | SPRINGWORKS THERAPEUTICS INC ORDINARY SHARES | 64.387 € | 2.21% | 0.75% |
13 | SYNDAX PHARMACEUTICALS INC | 63.974 € | 2.2% | 33.37% |
14 | GENMAB A/S | 61.826 € | 2.12% | 14.06% |
15 | PROTAGONIST THERAPEUTICS INC | 58.685 € | 2.02% | 15.27% |
16 | NEUROCRINE BIOSCIENCES INC | 58.671 € | 2.02% | 2.6% |
17 | MEDTRONIC PLC | 55.553 € | 1.91% | 5.02% |
18 | MADRIGAL PHARMACEUTICALS INC | 53.947 € | 1.85% | 13.97% |
19 | ABBVIE INC | 53.895 € | 1.85% | 7.2% |
20 | EDWARDS LIFESCIENCES CORP | 50.483 € | 1.73% | 17.07% |
21 | MIRUM PHARMACEUTICALS INC | 47.928 € | 1.65% | 25.15% |
22 | CYTOKINETICS INC | 44.800 € | 1.54% | 10.16% |
23 | SAREPTA THERAPEUTICS INC | 44.276 € | 1.52% | 20.37% |
24 | IDEAYA BIOSCIENCES INC | 42.002 € | 1.44% | 24.26% |
25 | ARCUTIS BIOTHERAPEUTICS INC ORDINARY SHARES | 40.715 € | 1.4% | 285.05% |
26 | PLIANT THERAPEUTICS INC ORDINARY SHARES | 40.478 € | 1.39% | 26.77% |
27 | GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 39.721 € | 1.36% | 3.82% |
28 | RESMED INC | 39.098 € | 1.34% | 23.63% |
29 | MINERALYS THERAPEUTICS INC | 38.429 € | 1.32% | 8.87% |
30 | KURA ONCOLOGY INC | 38.422 € | 1.32% | 56.23% |
31 | CULLINAN THERAPEUTICS INC | 37.059 € | 1.27% | 27.73% |
32 | KYMERA THERAPEUTICS INC ORDINARY SHARES | 36.449 € | 1.25% | 39.46% |
33 | CRINETICS PHARMACEUTICALS INC | 35.953 € | 1.24% | 18.12% |
34 | THERMO FISHER SCIENTIFIC INC | 34.672 € | 1.19% | 2.65% |
35 | DANAHER CORP | 32.593 € | 1.12% | 4.93% |
36 | PENUMBRA INC | 31.196 € | 1.07% | 36.54% |
37 | REGENERON PHARMACEUTICALS INC | 30.962 € | 1.06% | 29.87% |
38 | SANOFI SA ADR | 30.001 € | 1.03% | 2.86% |
39 | ROCHE HOLDING AG ADR | 28.536 € | 0.98% | 4.1% |
40 | AMICUS THERAPEUTICS INC | 28.143 € | 0.97% | 1.74% |
41 | BECTON DICKINSON & CO | 26.077 € | 0.9% | 0.45% |
42 | MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 23.850 € | 0.82% | 27.43% |
43 | 89BIO INC ORDINARY SHARES | 23.567 € | 0.81% | 1.02% |
44 | ARVINAS INC | 23.368 € | 0.8% | 25.48% |
45 | BLUEPRINT MEDICINES CORP | 19.966 € | 0.69% | 16.26% |
46 | NOVARTIS AG ADR | 17.952 € | 0.62% | 5.42% |
47 | CG ONCOLOGY | 15.485 € | 0.53% | Nueva |
48 | STRUCTURE THERAPEUTI | 13.595 € | 0.47% | Nueva |
49 | 4D MOLECULAR THERAPEUTICS INC ORDINARY SHARES | 12.240 € | 0.42% | 72.54% |
50 | VERALTO CORP | 4820 € | 0.17% | 10.37% |
51 | SANDOZ GROUP AG ADR | 2973 € | 0.1% | 15.77% |
52 | BRIDGEBIO PHARMA INC | 0 € | Vendida | |
53 | NEUMORA THERAPEUTICS INC | 0 € | Vendida | |
54 | TANGO THERAPEUTICS INC | 0 € | Vendida | |
55 | VIRIDIAN THERAPEUTICS INC | 0 € | Vendida | |
56 | AKERO THERAPEUTICS INC | 0 € | Vendida | |
57 | CELLDEX THERAPEUTICS INC | 0 € | Vendida | |
58 | ARROWHEAD PHARMACEUTICALS INC | 0 € | Vendida | |
59 | ROCKET PHARMACEUTICALS INC | 0 € | Vendida | |
60 | KEROS THERAPEUTICS INC | 0 € | Vendida | |
61 | 百济神州有限公司 ADR | 0 € | Vendida | |
62 | ZIMMER BIOMET HOLDINGS INC | 0 € | Vendida |